ClinVar Miner

Submissions for variant NM_013275.6(ANKRD11):c.7111G>T (p.Ala2371Ser)

gnomAD frequency: 0.00002  dbSNP: rs747911603
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001069182 SCV001234334 uncertain significance KBG syndrome 2024-07-01 criteria provided, single submitter clinical testing This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 2371 of the ANKRD11 protein (p.Ala2371Ser). This variant is present in population databases (rs747911603, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with ANKRD11-related conditions. ClinVar contains an entry for this variant (Variation ID: 862455). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ANKRD11 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002365776 SCV002662649 uncertain significance Inborn genetic diseases 2020-03-11 criteria provided, single submitter clinical testing The p.A2371S variant (also known as c.7111G>T), located in coding exon 7 of the ANKRD11 gene, results from a G to T substitution at nucleotide position 7111. The alanine at codon 2371 is replaced by serine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Revvity Omics, Revvity RCV001069182 SCV003818618 uncertain significance KBG syndrome 2020-06-02 criteria provided, single submitter clinical testing
Clinical Genomics Laboratory, Washington University in St. Louis RCV001069182 SCV005045040 uncertain significance KBG syndrome 2023-12-19 criteria provided, single submitter clinical testing The ANKRD11 c.7111G>T (p.Ala2371Ser) variant, to our knowledge, has not been reported in the medical literature but has been reported in the ClinVar database as a germline variant of uncertain significance by three submitters. This variant is only observed on 1/124,112 alleles in the general population (gnomAD v.2.1.1), indicating it is not a common variant. Computational predictors suggest that the variant does not impact ANKRD11 function. Due to limited information, and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.